scholarly article | Q13442814 |
P433 | issue | 5 | |
P921 | main subject | eye disease | Q3041498 |
P1104 | number of pages | 10 | |
P304 | page(s) | 545-554 | |
P577 | publication date | 1996-05-01 | |
P1433 | published in | JAMA Ophthalmology | Q4787301 |
P1476 | title | Risk factors for central retinal vein occlusion. The Eye Disease Case-Control Study Group | |
P478 | volume | 114 |
Q80541296 | 807C/T polymorphism in platelet glycoprotein Ia gene is not associated with retinal vein occlusion |
Q36586154 | A longitudinal analysis of risk factors associated with central retinal vein occlusion |
Q34864758 | A patient with acute macular neuroretinopathy and central retinal vein occlusion |
Q38869809 | An Unusual Case of Central Retinal Vein Occlusion and Review of the Toxicity Profile of Regorafenib in GIST Patients. |
Q30382208 | Anterior chamber depth and angle-closure glaucoma after central retinal vein occlusion |
Q52584491 | Anti-VEGF treatment of macular edema associated with retinal vein occlusion: patterns of use and effectiveness in clinical practice (ECHO study report 2). |
Q35578994 | Association between retinal vein occlusion, axial length and vitreous chamber depth measured by optical low coherence reflectometry |
Q38376975 | Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4. |
Q33711660 | Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10. |
Q39761899 | Blinding bilateral hyperviscosity retinopathy in a 43-year-old nigerian male with lymphoplasmacytic lymphoma: a case report and management challenges |
Q43286564 | Cardiovascular risk factors and outcome in patients with retinal vein occlusion |
Q46366389 | Cavernous sinus thrombosis elicited by a central retinal vein venous stasis retinopathy |
Q38521654 | Central retinal vein occlusion resulting from anomalous retinal vascular anatomy in a 24-year-old man. |
Q37338461 | Central retinal vein occlusion: a case report and review of the literature |
Q92174371 | Clinical Characteristics of Patients With CRVO in One Eye With Subsequent RVO in The Fellow Eye: A Retrospective Observational Study |
Q35589694 | Clinical characteristics of retinal venous occlusions occurring at different sites |
Q33774801 | Clinical progress in impending central retinal vein occlusion |
Q37417708 | Combined cilioretinal artery and central vein occlusions in juvenile glaucoma |
Q37116742 | Comorbidities in combined retinal artery and vein occlusions |
Q37361031 | Comparison between glaucomatous and non-glaucomatous eyes with unilateral retinal vein occlusion in the fellow eye. |
Q92498322 | Comparison of systemic conditions at diagnosis between central retinal vein occlusion and branch retinal vein occlusion |
Q60927253 | Comparison of the efficacy and safety of drug therapies for macular edema secondary to central retinal vein occlusion |
Q35099333 | Comprehensive Review of the Effects of Diabetes on Ocular Health |
Q89970136 | Diabetes mellitus as a risk factor for retinal vein occlusion: A meta-analysis |
Q35407942 | Diagnostic ramifications of ocular vascular occlusion as a first thrombotic event associated with factor V Leiden and prothrombin gene heterozygosity |
Q42735697 | Efficacy of intravitreal triamcinolone for macular oedema due to CRVO after anti-androgen therapy for hirsutism in a young monocular female |
Q58110582 | Evaluating the neuroprotective effect of 17β-estradiol in rodent models of oxidative retinopathies |
Q30503125 | Follow up by colour Doppler imaging of 102 patients with retinal vein occlusion over 1 year |
Q37376288 | Glucose-6-phosphate dehydrogenase deficiency and diabetes mellitus with severe retinal complications in a Sardinian population, Italy |
Q28078201 | Guidance for the management of venous thrombosis in unusual sites |
Q24815630 | Homocysteine, MTHFR C677T gene polymorphism, folic acid and vitamin B 12 in patients with retinal vein occlusion |
Q35846918 | INITIAL EXPERIENCE WITH TRANSPUPILLARY DIODE LASER PHOTOCOAGULATION FOR RETINAL DISEASES. |
Q36802033 | Inflammation in retinal vein occlusion |
Q35094088 | Influence of diabetes and diabetes type on anatomic and visual outcomes following central rein vein occlusion |
Q35590626 | Influence of factor V Leiden on the development of neovascularisation secondary to central retinal vein occlusion |
Q33628064 | Intense exercise causing central retinal vein occlusion in a young patient: case report and review of the literature |
Q35908514 | Intraocular Pressure Reduction Is Associated with Reduced Venous Pulsation Pressure. |
Q60915689 | Intravitreal dexamethasone implants versus intravitreal anti-VEGF treatment in treating patients with retinal vein occlusion: a meta-analysis |
Q24187275 | Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion |
Q33844950 | Inverse association of female hormone replacement therapy with age-related macular degeneration and interactions with ARMS2 polymorphisms |
Q64080373 | Management of the open angle glaucoma in patients with central/hemicentral retinal vein occlusions |
Q48357210 | Measurement of lamina and prelaminar thicknesses of both eyes in patients with unilateral branch retinal vein occlusion. |
Q36842136 | Ocular associations of diabetes other than diabetic retinopathy |
Q35967871 | Ocular tissue responses to sex hormones |
Q40421525 | Prevalence and associated factors of retinal vein occlusion in the Korean National Health and Nutritional Examination Survey, 2008-2012: A cross-sectional observational study |
Q35867717 | Prevalence of comorbid retinal disease in patients with glaucoma at an academic medical center |
Q41595073 | Prevalence, pattern and risk factors of retinal vein occlusion in an elderly population in Nepal: the Bhaktapur retina study |
Q73482769 | Pseudoexfoliation and glaucoma in eyes with retinal vein occlusion |
Q55283872 | Recent advances in understanding and managing retinal vein occlusions. |
Q92534595 | Retinal capillary hemangioblastoma and hemiretinal vein occlusion in a patient with primary congenital glaucoma: A case report |
Q37170512 | Retinal vascular changes in hypertensive patients in Ibadan, Sub-Saharan Africa |
Q37174819 | Retinal vascular occlusion: a window to diagnosis of familial and acquired thrombophilia and hypofibrinolysis, with important ramifications for pregnancy outcomes |
Q24596993 | Retinal vein occlusion: pathophysiology and treatment options |
Q37872641 | Retinal vein occlusions: a review for the internist |
Q42339098 | Retinal vein pulsation predicts increasing optic disc excavation |
Q34604239 | Retino-choroidal ischemia in central retinal vein occlusion |
Q30835869 | Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data |
Q36838150 | Risk of Retinal Vein Occlusion Following End-Stage Renal Disease |
Q39114176 | Role of Lipids in Retinal Vascular and Macular Disorders. |
Q33402708 | SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion |
Q33484531 | SCORE Study report 3: study design and baseline characteristics |
Q46169738 | SCORE2 Report 2: Study Design and Baseline Characteristics |
Q92642574 | Spectrum of Eye Disease in Diabetes (SPEED) in India: A prospective facility-based study. Report # 3. Retinal vascular occlusion in patients with type 2 diabetes mellitus |
Q99565681 | Spinal cord infarction associated to retinal vein occlusion in a patient with chronic kidney disease |
Q36188910 | Stromal Cell-Derived Factor 1 Polymorphism in Retinal Vein Occlusion |
Q37669502 | Systemic abnormalities associated with retinal vein occlusion in young patients |
Q36452434 | The future of glaucoma clinics |
Q34795992 | The incidence of retinal vein occlusion in the ocular hypertension treatment study |
Q36276933 | The relation between exercise and glaucoma in a South Korean population-based sample |
Q91905966 | The short-term effects of intravitreal aflibercept injections and dexamethasone implant on ocular hemodynamics in retinal vein occlusions |
Q53608866 | The tipping point: Tamoxifen toxicity, central serous chorioretinopathy, and the role of estrogen and its receptors. |
Q36490483 | Therapeutic potential of intravitreal pharmacotherapy in retinal vein occlusion |
Q36014793 | Value of retinal vein pulsation characteristics in predicting increased optic disc excavation |
Q41110296 | Vascular Occlusions following Ocular Surgical Procedures: A Clinical Observation of Vascular Complications after Ocular Surgery. |
Q33572207 | Venous retinal flow reperfusion mechanisms following radial optic neurotomy with adjunctive intraocular triamcinolone in central retinal vein occlusion |
Q46523816 | Vitrectomy and radial optic neurotomy for central retinal vein occlusion: effects on visual acuity and macular anatomy |
Q24813398 | Vitrectomy with complete posterior hyaloid removal for ischemic central retinal vein occlusion: series of cases |
Q83095992 | [Ophthalmological findings as a hint for systemic disease] |
Q80307436 | [Radial optic neurotomy: efficacy monitoring using venous ophthalmodynamometry] |
Q83348014 | [Thrombophilic and systemic risk factors in patients with retinal vein occlusion] |
Search more.